FDA Inspection
The Queen's Medical Center IRBThe Queen's Medical Center IRB – FDA Inspection, Jul 21, 2017
Record Details
This FDA Inspection record concerns The Queen's Medical Center IRB, with an inspection on July 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Sherri J. Jackson (Issuing Officer)
View Company Profile
ID · d5e28d34-685a-4f6c-a3a0-562a56e258ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1025042
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of The Queen's Medical Center IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 6, 2009 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for The Queen's Medical Center IRB
- FDA Inspection 1239051 - 2024-04-11
- FDA Inspection 583294 - 2009-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.